Related Experiment Video
Updated: May 7, 2026

06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
4.0K
The EBV-autoimmunity axis: mechanistic insights in SLE, MS and PSC
Seyhan Yazar1,2, Nicholas Schwab3, Nicholas S R Sanderson4,5
1Precision Immunology Program, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Immunology and Cell Biology
|May 6, 2026
Summary
Epstein-Barr virus nuclear antigen 2 (EBNA2) hijacks host cell enhancers in memory B cells. This epigenetic reprogramming transforms these cells into highly efficient antigen-presenting cells (APCs).
Area of Science:
- Immunology
- Epigenetics
- Virology
Background:
- Epstein-Barr virus (EBV) infects B cells, establishing latency.
- Memory B cells are crucial for adaptive immunity.
- The role of EBV's EBNA2 in B cell reprogramming is under investigation.
Purpose of the Study:
- To investigate how EBNA2 mediates host enhancer hijacking.
- To understand the impact of EBNA2 on B cell identity and function.
- To elucidate the mechanisms behind B cell reprogramming into antigen-presenting cells (APCs).
Main Methods:
- Analysis of EBV-infected CD27+ CD21low memory B cells.
- Epigenetic analysis of host cell enhancer regions.
- Transcriptomic and immunophenotypic profiling.
Main Results:
- Latent EBNA2 was observed in memory B cells.
- EBNA2 acts as an epigenetic remodeler, binding to host enhancers.
- This hijacking disrupts B cell identity, upregulating TBX21 (T-bet), ZEB2, and MHC class II machinery.
- Reprogrammed B cells exhibit hyper-efficient APC function.
Conclusions:
- EBNA2-mediated enhancer hijacking is a key mechanism in EBV-driven B cell reprogramming.
- This process converts memory B cells into potent APCs, potentially impacting immune responses.
- Understanding this reprogramming is vital for EBV pathogenesis and therapeutic strategies.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
32
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
32
Autoimmune Disorders
2.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
B Cell Activation and Differentiation
14.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.6K
Encephalitis ll: Pathophysiology
32
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
32

